BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20612)

  • 1. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives. Part III. The use of Hammett equation for kinetic investigation of 2-sulfanilamidopyrimidine derivatives autoxidation.
    Zajac M
    Pol J Pharmacol Pharm; 1977; 29(4):445-50. PubMed ID: 20612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives. Part VI. The use of Hammett equation for kinetic investigation of 2-sulfanilamidopyrimidine derivatives hydrolysis.
    Zajac M
    Pol J Pharmacol Pharm; 1977; 29(6):689-96. PubMed ID: 600868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives. Part 2. Log k--pH profile for sulfadimidine autoxidation.
    Zajac M
    Pol J Pharmacol Pharm; 1976; 28(5):545-50. PubMed ID: 13352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives: part IV. Mechanism and kinetics of specific acid-catalyzed hydrolysis of sulfadimidine.
    Zajac M
    Pol J Pharmacol Pharm; 1977; 29(5):555-63. PubMed ID: 22848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of drug decomposition. Part 37. Kinetics of autoxidation of narcotine in aqueous solutions.
    Pawelczyk E; Zajac M; Matlak B
    Pol J Pharmacol Pharm; 1976; 28(1):69-76. PubMed ID: 1264860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives. Part 1. Log k--pH profile for sulfadimidine solvolysis.
    Zajac M
    Pol J Pharmacol Pharm; 1976; 28(5):495-503. PubMed ID: 13351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed spectroscopic, thermodynamic, and kinetic studies on the protolytic equilibria of Fe(III)cydta and the activation of hydrogen peroxide.
    Brausam A; Maigut J; Meier R; Szilágyi PA; Buschmann HJ; Massa W; Homonnay Z; van Eldik R
    Inorg Chem; 2009 Aug; 48(16):7864-84. PubMed ID: 19618946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of drug decomposition. Part XXXVI. Stability of 10-(1'-methyl-4'-piperazinylpropyl)-phenothiazine derivatives on the grounds of kinetics of thermal degradation and Hammett equation.
    Pawelczyk E; Marciniec B; Matlak B
    Pol J Pharmacol Pharm; 1975; 27(3):317-25. PubMed ID: 1144210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of drug decomposition. Part 38. Hydrolysis and autoxidation of sodium phenylbutazone and aminophenazone in binary kinetic system.
    Pawelczyk E; Wachowiak R
    Pol J Pharmacol Pharm; 1976; 28(3):287-94. PubMed ID: 7777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and mechanism of degradation of some 2-sulfanilamidopyrimidine derivatives. Part V. Mechanism of sulfadimidine solvolysis.
    Zajac M
    Pol J Pharmacol Pharm; 1977; 29(6):683-8. PubMed ID: 600867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical investigation of decomposition processes of pyrazolidine-3,5-dione derivatives. Part 3. Kinetics and mechanism of degradation of ketazone in aqueous solutions and solid phase.
    Wachowiak R
    Pol J Pharmacol Pharm; 1978; 30(6):833-43. PubMed ID: 39293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of drug decomposition. Part 74. Kinetics of degradation of minocycline in aqueous solution.
    Pawełczyk E; Matlak B
    Pol J Pharmacol Pharm; 1982; 34(5-6):409-21. PubMed ID: 7187051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorination of 2-phenoxypropanoic acid with NCP in aqueous acetic acid: using a novel ortho-para relationship and the para/meta ratio of substituent effects for mechanism elucidation.
    Segurado MA; Reis JC; de Oliveira JD; Kabilan S; Shanthi M
    J Org Chem; 2007 Jul; 72(14):5327-36. PubMed ID: 17567074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of new analgesic active compound, pyrrolo-[3,4-c]pyridine derivative, in aqueous solutions.
    Muszalska I; Wojtyniak E
    Acta Pol Pharm; 2007; 64(4):319-25. PubMed ID: 18536157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic kinetics in the reaction between amino acids or glutathione and the chromium acetate cluster, [Cr3O(OAc)6]+.
    Chaudhary S; Van Horn JD
    Mutat Res; 2006 Nov; 610(1-2):56-65. PubMed ID: 16890480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein aggregation variable temperature and variable pH kinetic data: a re-analysis using the Finke-Watzky 2-step model of nucleation and autocatalytic growth.
    Morris AM; Finke RG
    Biophys Chem; 2009 Mar; 140(1-3):9-15. PubMed ID: 19101068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on decomposition kinetics of thalidasine in aqueous solution].
    Ma WL; Su DS; Gu XQ
    Yao Xue Xue Bao; 1991; 26(1):59-63. PubMed ID: 1887796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of drug decomposition. Part 45. Logk--pH profile for rolitetracycline degradation.
    Pawelczyk E; Hermann T; Plotkowiak Z; Matlak B
    Pol J Pharmacol Pharm; 1977; 29(4):431-44. PubMed ID: 20611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equilibrium studies for trimethoprim adsorption on montmorillonite KSF.
    Bekçi Z; Seki Y; Yurdakoç MK
    J Hazard Mater; 2006 May; 133(1-3):233-42. PubMed ID: 16310307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions.
    Simoncic Z; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2008 May; 356(1-2):200-5. PubMed ID: 18304767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.